Literature DB >> 14715811

First report of a case of meningitis caused by Cryptococcus adeliensis in a patient with acute myeloid leukemia.

Dagmar Rimek1, Gerhard Haase, Andreas Lück, Jochen Casper, Andreas Podbielski.   

Abstract

Cryptococcus adeliensis is a recently described new fungal species which has been isolated from decaying algae in Terre Adelie, Antarctica. We report the first known case of meningitis caused by C. adeliensis in a patient with acute myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.

Entities:  

Mesh:

Year:  2004        PMID: 14715811      PMCID: PMC321734          DOI: 10.1128/JCM.42.1.481-483.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.

Authors:  Sharon C A Chen
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

3.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Authors:  M S Saag; R J Graybill; R A Larsen; P G Pappas; J R Perfect; W G Powderly; J D Sobel; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.

Authors:  A I Aller; E Martín-Mazuelos; M J Gutiérrez; S Bernal; M Chávez; F J Recio
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

5.  Xylanase from the psychrophilic yeast Cryptococcus adeliae.

Authors:  I Petrescu; J Lamotte-Brasseur; J P Chessa; P Ntarima; M Claeyssens; B Devreese; G Marino; C Gerday
Journal:  Extremophiles       Date:  2000-06       Impact factor: 2.395

6.  Pulmonary cryptococcosis. A case due to Cryptococcus albidus.

Authors:  R A Krumholz
Journal:  Am Rev Respir Dis       Date:  1972-03

7.  First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.

Authors:  T Kordossis; A Avlami; A Velegraki; I Stefanou; G Georgakopoulos; C Papalambrou; N J Legakis
Journal:  Med Mycol       Date:  1998-10       Impact factor: 4.076

8.  Intraspecies diversity of Cryptococcus albidus isolated from humans as revealed by sequences of the internal transcribed spacer regions.

Authors:  T Sugita; M Takashima; R Ikeda; T Nakase; T Shinoda
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

9.  Diversity in the yeast Cryptococcus albidus and related species as revealed by ribosomal DNA sequence analysis.

Authors:  A Fonseca; G Scorzetti; J W Fell
Journal:  Can J Microbiol       Date:  2000-01       Impact factor: 2.419

10.  Cryptococcus adeliensis sp. nov., a xylanase producing basidiomycetous yeast from Antarctica.

Authors:  G Scorzetti; I Petrescu; D Yarrow; J W Fell
Journal:  Antonie Van Leeuwenhoek       Date:  2000-02       Impact factor: 2.271

View more
  11 in total

1.  Isolation of Cryptococcus adeliensis from clinical samples and the environment in Germany.

Authors:  Kathrin Tintelnot; Heidemarie Losert
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

2.  Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS.

Authors:  Esaki Muthu Shankar; Nagalingeswaran Kumarasamy; Devaleenol Bella; Srinivasan Renuka; Hayak Kownhar; Solomon Suniti; Ramachandra Rajan; Usha Anand Rao
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

3.  Atypical Morphology and Disparate Speciation in a Case of Feline Cryptococcosis.

Authors:  S J M Evans; K Jones; A R Moore
Journal:  Mycopathologia       Date:  2017-07-29       Impact factor: 2.574

Review 4.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

5.  Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.

Authors:  Shiang Ning Leaw; Hsien Chang Chang; Hsiao Fang Sun; Richard Barton; Jean-Philippe Bouchara; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

6.  Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities.

Authors:  A Serda Kantarcioğlu; Teun Boekhout; G Sybren De Hoog; Bart Theelen; Ayhan Yücel; Tuba R Ekmekci; Bettina C Fries; Reiko Ikeda; Adem Koslu; Kemal Altas
Journal:  Med Mycol       Date:  2007-03       Impact factor: 4.076

7.  Phylogeny and phenotypic characterization of pathogenic Cryptococcus species and closely related saprobic taxa in the Tremellales.

Authors:  Keisha Findley; Marianela Rodriguez-Carres; Banu Metin; Johannes Kroiss; Alvaro Fonseca; Rytas Vilgalys; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2009-01-16

8.  Isolation and molecular characterization of Cryptococcus species isolated from pigeon nests and Eucalyptus trees.

Authors:  A Kamari; A Sepahvand; R Mohammadi
Journal:  Curr Med Mycol       Date:  2017-06

9.  Titan cell formation is unique to Cryptococcus species complex.

Authors:  Mariusz Dyląg; Rodney J Colon-Reyes; Lukasz Kozubowski
Journal:  Virulence       Date:  2020-01-01       Impact factor: 5.882

10.  Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

Authors:  Edison J Cano; Zachary A Yetmar; Raymund R Razonable
Journal:  Open Forum Infect Dis       Date:  2020-10-29       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.